133 related articles for article (PubMed ID: 25663449)
21. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
23. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.
Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S
Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA genetic variations: association with type 2 diabetes.
Ciccacci C; Di Fusco D; Cacciotti L; Morganti R; D'Amato C; Greco C; Rufini S; Novelli G; Sangiuolo F; Spallone V; Borgiani P
Acta Diabetol; 2013 Dec; 50(6):867-72. PubMed ID: 23532299
[TBL] [Abstract][Full Text] [Related]
25. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
Srivastava K; Srivastava A; Mittal B
J Hum Genet; 2010 Aug; 55(8):495-9. PubMed ID: 20520619
[TBL] [Abstract][Full Text] [Related]
26. Genetic variations in microRNAs and the risk and survival of renal cell cancer.
Du M; Lu D; Wang Q; Chu H; Tong N; Pan X; Qin C; Yin C; Wang M; Zhang Z
Carcinogenesis; 2014 Jul; 35(7):1629-35. PubMed ID: 24681820
[TBL] [Abstract][Full Text] [Related]
27. Glutathione S-transferase polymorphisms in osteosarcoma patients.
Salinas-Souza C; Petrilli AS; de Toledo SR
Pharmacogenet Genomics; 2010 Aug; 20(8):507-15. PubMed ID: 20577141
[TBL] [Abstract][Full Text] [Related]
28. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.
Ahn DH; Rah H; Choi YK; Jeon YJ; Min KT; Kwack K; Hong SP; Hwang SG; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E39-51. PubMed ID: 23001871
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
[TBL] [Abstract][Full Text] [Related]
30. Major efficacy of trabectedin in 2 metastatic osteosarcoma patients with wild-type Asp1104 ERCC5 tumor status.
Gastaud L; Saâda-Bouzid E; Le Morvan V; Pourquier P; Ianessi A; Thariat J; Italiano A; Thyss A
Onkologie; 2013; 36(11):670-3. PubMed ID: 24192772
[TBL] [Abstract][Full Text] [Related]
31. A miR-SNP of the KRT81 gene is associated with the prognosis of non-Hodgkin's lymphoma.
Xie Y; Diao L; Zhang L; Liu C; Xu Z; Liu S
Gene; 2014 Apr; 539(2):198-202. PubMed ID: 24530479
[TBL] [Abstract][Full Text] [Related]
32. A causal role for circulating miR-34b in osteosarcoma.
Tian Q; Jia J; Ling S; Liu Y; Yang S; Shao Z
Eur J Surg Oncol; 2014 Jan; 40(1):67-72. PubMed ID: 24063968
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.
Won KY; Kim YW; Kim HS; Lee SK; Jung WW; Park YK
Hum Pathol; 2013 Aug; 44(8):1648-55. PubMed ID: 23574781
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma.
Mirabello L; Yu K; Berndt SI; Burdett L; Wang Z; Chowdhury S; Teshome K; Uzoka A; Hutchinson A; Grotmol T; Douglass C; Hayes RB; Hoover RN; Savage SA;
BMC Cancer; 2011 May; 11():209. PubMed ID: 21619704
[TBL] [Abstract][Full Text] [Related]
35. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
[TBL] [Abstract][Full Text] [Related]
36. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
[TBL] [Abstract][Full Text] [Related]
37. Germline hereditary, somatic mutations and microRNAs targeting-SNPs in congenital heart defects.
Sabina S; Pulignani S; Rizzo M; Cresci M; Vecoli C; Foffa I; Ait-Ali L; Pitto L; Andreassi MG
J Mol Cell Cardiol; 2013 Jul; 60():84-9. PubMed ID: 23583740
[TBL] [Abstract][Full Text] [Related]
38. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer.
Lee SJ; Seo JW; Chae YS; Kim JG; Kang BW; Kim WW; Jung JH; Park HY; Jeong JY; Park JY
Anticancer Res; 2014 Jun; 34(6):2943-9. PubMed ID: 24922658
[TBL] [Abstract][Full Text] [Related]
40. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients.
Koshkina NV; Kleinerman ES; Li G; Zhao CC; Wei Q; Sturgis EM
J Pediatr Hematol Oncol; 2007 Dec; 29(12):815-21. PubMed ID: 18090928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
